Head and neck cancer antigens recognized by the humoral immune system.

Head and neck cancer in advanced stages are difficult to treat. Therefore, development of new treatment modalities and preventive measures are required. We now report the identification of human head and neck cancer antigens recognized by the humoral immune system. We used the serological analysis of recombinant cDNA expression libraries (SEREX) approach. cDNA libraries from cell lines of squamous cell carcinoma of head and neck (SCCHN) and a normal testicle tissue were screened using sera from six allogeneic SCCHN patients. Total 28 positive clones belonging to 19 different genes were identified, including 12 known genes and 7 unknown ones. Expression analysis on 13 normal tissues and 13 cancer tissues using reverse transcription-PCR (RT-PCR) revealed eight ubiquitously expressed genes, nine of which were expressed preferentially in cancer tissues and two cancer/testis antigens. These antigens we defined may be pertinent candidate antigens for future cancer-diagnosis and related immunotherapy.

[1]  M. Scheffner,et al.  Ubiquitin, E6-AP, and their role in p53 inactivation. , 1998, Pharmacology & therapeutics.

[2]  Pei-shan Wu,et al.  Biochemical and Biophysical Research Communications , 1960, Nature.

[3]  G. Nabel,et al.  Cloning of RкB, a novel DNA-binding protein that recognizes the interleukin-2 receptor α chain кB site: New Biol. 3, 1063–1073 , 1992 .

[4]  K. Itoh,et al.  An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. , 1997, Biochemical and biophysical research communications.

[5]  K. Hashimoto,et al.  Cloning, expression analysis and chromosome mapping of human casein kinase 1 γ1 (CSNK1G1): Identification of two types of cDNA encoding the kinase protein associated with heterologous carboxy-terminal sequences , 2000, Cytogenetic and Genome Research.

[6]  P. Coulie,et al.  High-resolution structure of HLA-A*0201 in complex with a tumour-specific antigenic peptide encoded by the MAGE-A4 gene. , 2001, Journal of molecular biology.

[7]  K. Masuyama,et al.  Functional and T Cell Receptor Gene Usage Analysis of Cytotoxic T Lymphocytes in Fresh Tumor‐infiltrating Lymphocytes from Human Head and Neck Cancer , 1995, Japanese journal of cancer research : Gann.

[8]  P. Wingo,et al.  Cancer statistics, 1996 , 1996, CA: a cancer journal for clinicians.

[9]  L. C. Robinson,et al.  Casein kinase I gamma subfamily. Molecular cloning, expression, and characterization of three mammalian isoforms and complementation of defects in the Saccharomyces cerevisiae YCK genes. , 1995, The Journal of biological chemistry.

[10]  Yao-Tseng Chen,et al.  A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[11]  F. Brasseur,et al.  A CASP-8 Mutation Recognized by Cytolytic T Lymphocytes on a Human Head and Neck Carcinoma , 1997, The Journal of experimental medicine.

[12]  I. Rabinovitz,et al.  The integrin alpha 6 beta 4 and the biology of carcinoma. , 1996, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[13]  C. Waes,et al.  The A9 Antigen Associated with Aggressive Human Squamous Carcinoma Is Structurally and Functionally Similar to the Newly Defined Integrin α6β4 , 1991 .

[14]  P. Chomez,et al.  A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. , 1991, Science.

[15]  L. Spremulli,et al.  The Small Subunit of the Mammalian Mitochondrial Ribosome , 2001, The Journal of Biological Chemistry.

[16]  M. Pfreundschuh,et al.  Identification of a meiosis-specific protein as a member of the class of cancer/testis antigens. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[17]  C. Van Waes,et al.  The A9 antigen associated with aggressive human squamous carcinoma is structurally and functionally similar to the newly defined integrin alpha 6 beta 4. , 1991, Cancer research.

[18]  G. Blobel,et al.  Cloning and characterization of human karyopherin beta3. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[19]  M. Pfreundschuh,et al.  Human neoplasms elicit multiple specific immune responses in the autologous host. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[20]  S. Senju,et al.  Gene cloning of immunogenic antigens overexpressed in pancreatic cancer. , 2001, Biochemical and biophysical research communications.

[21]  G. Blobel,et al.  Cloning and characterization of human karyopherin β3 , 1997 .

[22]  S. D. Gross,et al.  Casein kinase I: spatial organization and positioning of a multifunctional protein kinase family. , 1998, Cellular signalling.

[23]  Y. Kan,et al.  NRF2, a member of the NFE2 family of transcription factors, is not essential for murine erythropoiesis, growth, and development. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[24]  P. Coulie,et al.  The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas , 1993, The Journal of experimental medicine.

[25]  G. Iliakis,et al.  Replication protein A2 phosphorylation after DNA damage by the coordinated action of ataxia telangiectasia-mutated and DNA-dependent protein kinase. , 2001, Cancer research.

[26]  S. Senju,et al.  Identification of a novel autoantigen UACA in patients with panuveitis. , 2001, Biochemical and biophysical research communications.

[27]  D. Schadendorf,et al.  Serological detection of cutaneous T-cell lymphoma-associated antigens. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[28]  K. Itoh,et al.  A newly identified MAGE‐3‐derived epitope recognized by HLA‐A24‐restricted cytotoxic T lymphocytes , 1999, International journal of cancer.

[29]  E. Appella,et al.  A wild-type sequence p53 peptide presented by HLA-A24 induces cytotoxic T lymphocytes that recognize squamous cell carcinomas of the head and neck. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[30]  R. Kroes,et al.  The identification of novel therapeutic targets for the treatment of malignant brain tumors. , 2000, Cancer letters.

[31]  Masaaki Ito,et al.  Identification of SART3‐derived peptides capable of inducing HLA‐A2‐restricted and tumor‐specific CTLs in cancer patients with different HLA‐A2 subtypes , 2000, International journal of cancer.

[32]  D. Jäger,et al.  Monitoring CD8 T cell responses to NY-ESO-1: correlation of humoral and cellular immune responses. , 2000, Proceedings of the National Academy of Sciences of the United States of America.